During the past decade, Eastern Health Integrated Renal Service conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Eastern Health Integrated Renal Service" are "End-stage Renal Disease" (1 trials), "Hemodiafiltration" (1 trials), "Hemodialysis" (1 trials), "Lymphoma, Non-Hodgkin" (1 trials) and "Non-diabetic Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Eastern Health Integrated Renal Service" in a lesser frequency.

Most popular intervention types in "Eastern Health Integrated Renal Service" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "BAY1213790 (Osocimab)" (1 trials), "Bendamustine" (1 trials), "Copanlisib (BAY80-6946)" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eastern Health Integrated Renal Service" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Eastern Health Integrated Renal Service". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Eastern Health Integrated Renal Service, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eastern Health Integrated Renal Service, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".